Controlant has become a sponsor for Gulleggið, Iceland’s leading start-up competition, in recognition of the importance of supporting innovation and entrepreneurship.
Controlant has become a sponsor for Gulleggið, Iceland’s leading start-up competition, in recognition of the importance of supporting innovation and entrepreneurship. In 2009, Controlant’s founders won the competition and benefited greatly from the encouragement and practical assistance when developing the company.
Controlant celebrates its 15th anniversary this year and the company has grown exponentially since it won the Gulleggið, with 420 employees across five countries, developing, manufacturing, and servicing monitoring solutions used by the world’s largest pharmaceutical companies. Controlant’s solutions ensure medicines and vaccines are delivered safely and smoothly to the people who need them.
The company has earned international recognition and won numerous awards including the 2022 GLOMO Award for Best Innovation for COVID-19 Pandemic Response and Recovery, The Growth Sprout 2022, the President of Iceland’s Export Award 2021, the 2020 SDCE Green Supply Chain Award, and the Icelandic Innovation Prize 2020.
Continued growth is expected as the need for safe, efficient, traceable, and sustainable transportation of sensitive medicines will only grow in the coming years.
Controlant is proud to continue laying the foundation for innovation by supporting entrepreneurs who are now at the start of their own journeys, striving to put their ideas into practice.
“It was a tremendous encouragement for us to win Gulleggið. We were then a traditional company with very few employees, and insignificant income, but we had big aspirations. Following the recognition and support from Rannís, the ball started to roll since we could recruit great people and investors to pursue big ideas. We are delighted to now be able to give back and support the innovation community in Iceland. After all, it is the foundation for future entrepreneurs.”
“Let’s not forget, Controlant is the first recipient of Gulleggið to become a sponsor of the entrepreneurial competition. It is the company we refer to when we talk about the success of the Gulleggið, and their sponsorship is very important to us. Not only do they give the competition financial strength, but they bring in experience and knowledge that will definitely give us more powerful Gulleggið successes in the future.”
The promise of modern medicine to improve lives and cure more diseases than ever before can only be fulfilled when pharma supply chains provide on-time, safe, and sustainable delivery to patients wherever they may be. Digitalization is the key to unlocking the potential of supply chains to be a strategic enabler in today’s complex and ever-changing market and to achieve zero waste. Controlant’s validated, cloud-based Aurora Platform can be coupled with devices and services for a holistic solution framework designed to digitalize and automate pharma supply chains.
The Science Based Targets initiative (SBTi) has validated Controlant’s near-term climate target to reduce scope 1 and 2 greenhouse gas (GHG) emissions by 42% by 2030. With a validated target, Controlant becomes one of the first companies among its global industry peers to have a validated science-based target. Joining the initiative is a vital step for Controlant in its mission to deliver zero-waste pharma supply chains and ensure its climate actions are in line with the latest climate science.
UNICEF and Controlant have signed a partnership agreement with a focus on life-saving child immunization. Over the next three years, Controlant will donate to UNICEF yearly for its tireless work that has a direct, positive impact on children across the world.